Panchsheel Organics Limited (BOM:531726)

Market Cap	1.56B -13.7%
Revenue (ttm)	1.08B +2.9%
Net Income	102.97M -22.1%
EPS	7.82 -22.0%
Shares Out	13.17M
PE Ratio	15.18
Forward PE	n/a
Dividend	3.20 (2.70%)
Ex-Dividend Date	Aug 21, 2026

Volume	3,380
Open	121.90
Previous Close	120.80
Day's Range	118.70 - 124.50
52-Week Range	86.10 - 158.65
Beta	0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Panchsheel Organics

Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. Panchsheel Org...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 185
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531726

Financial Performance

In fiscal year 2026, Panchsheel Organics's revenue was 1.07 billion, a decrease of -0.37% compared to the previous year's 1.07 billion. Earnings were 108.30 million, a decrease of -21.49%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 22, 2026

Data Sources Report a data error